시장조사 보고서 : 세계의 마이크로바이옴 치료제 시장예측 2021년-2026년

■ 영문 제목 : Global Microbiome Therapeutics Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02229 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 120 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 마이크로바이옴 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (상부 소화관, 하부 소화관)와 용도별 시장규모 (C. 디피실 감염증 (CDI), 염증성 장질환 (IBD), 희귀병용 의약품, 면역 종양학, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 마이크로바이옴 치료제 시장 점유율
- 지역별 마이크로바이옴 치료제 시장규모
- 주요지역의 종류별 시장규모 (상부 소화관, 하부 소화관)
- 주요지역의 용도별 시장규모 (C. 디피실 감염증 (CDI), 염증성 장질환 (IBD), 희귀병용 의약품, 면역 종양학, 기타)
- 미주의 마이크로바이옴 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 마이크로바이옴 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 마이크로바이옴 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 마이크로바이옴 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 마이크로바이옴 치료제 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma, Second Genome, AOBiome, C3 Jian, Rebiotix, MicroBiome Therapeutics LLC, Metabiomics, Ritter Pharmaceuticals, Symberix, OpenBiome, Azitra, Symbiotix Biotherapies, Osel, Metabogen
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Microbiome Therapeutics will have significant change from previous year. By the most conservative estimates of global Microbiome Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 51 million in 2020. Over the next five years the Microbiome Therapeutics market will register a 39.5% CAGR in terms of revenue, the global market size will reach US$ 193.4 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Microbiome Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Upper GIT
Lower GIT

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microbiome Therapeutics Market Size 2016-2026
2.1.2 Microbiome Therapeutics Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Microbiome Therapeutics Segment by Type
2.2.1 Upper GIT
2.2.2 Upper GIT
2.3 Microbiome Therapeutics Market Size by Type
2.3.1 Global Microbiome Therapeutics Market Size CAGR by Type
2.3.2 Global Microbiome Therapeutics Market Size Market Share by Type (2016-2021)
2.4 Microbiome Therapeutics Segment by Application
2.4.1 C. difficile Infection (CDI)
2.4.2 Inflammatory Bowel Disease (IBD)
2.4.3 Orphan Drug
2.4.4 Immuno-oncology
2.4.5 Others
2.5 Microbiome Therapeutics Market Size by Application
2.5.1 Global Microbiome Therapeutics Market Size CAGR by Application
2.5.2 Global Microbiome Therapeutics Market Size Market Share by Application (2016-2021)

3 Microbiome Therapeutics Market Size by Players
3.1 Microbiome Therapeutics Market Size Market Share by Players
3.1.1 Global Microbiome Therapeutics Revenue by Players (2019-2021E)
3.1.2 Global Microbiome Therapeutics Revenue Market Share by Players (2019-2021E)
3.2 Global Microbiome Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Microbiome Therapeutics by Regions
4.1 Microbiome Therapeutics Market Size by Regions (2016-2021)
4.2 Americas Microbiome Therapeutics Market Size Growth (2016-2021)
4.3 APAC Microbiome Therapeutics Market Size Growth (2016-2021)
4.4 Europe Microbiome Therapeutics Market Size Growth (2016-2021)
4.5 Middle East & Africa Microbiome Therapeutics Market Size Growth (2016-2021)

5 Americas
5.1 Americas Microbiome Therapeutics Market Size by Country (2016-2021)
5.2 Americas Microbiome Therapeutics Market Size by Type (2016-2021)
5.3 Americas Microbiome Therapeutics Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Microbiome Therapeutics Market Size by Region (2016-2021)
6.2 APAC Microbiome Therapeutics Market Size by Type (2016-2021)
6.3 APAC Microbiome Therapeutics Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Microbiome Therapeutics by Country (2016-2021)
7.2 Europe Microbiome Therapeutics Market Size by Type (2016-2021)
7.3 Europe Microbiome Therapeutics Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Microbiome Therapeutics by Region (2016-2021)
8.2 Middle East & Africa Microbiome Therapeutics Market Size by Type (2016-2021)
8.3 Middle East & Africa Microbiome Therapeutics Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Microbiome Therapeutics Market Forecast
10.1 Global Microbiome Therapeutics Forecast by Regions (2021-2026)
10.1.1 Global Microbiome Therapeutics Forecast by Regions (2021-2026)
10.1.2 Americas Microbiome Therapeutics Forecast
10.1.3 APAC Microbiome Therapeutics Forecast
10.1.4 Europe Microbiome Therapeutics Forecast
10.1.5 Middle East & Africa Microbiome Therapeutics Forecast
10.2 Americas Microbiome Therapeutics Forecast by Countries (2021-2026)
10.2.1 United States Microbiome Therapeutics Market Forecast
10.2.2 Canada Microbiome Therapeutics Market Forecast
10.2.3 Mexico Microbiome Therapeutics Market Forecast
10.2.4 Brazil Microbiome Therapeutics Market Forecast
10.3 APAC Microbiome Therapeutics Forecast by Region (2021-2026)
10.3.1 China Microbiome Therapeutics Market Forecast
10.3.2 Japan Microbiome Therapeutics Market Forecast
10.3.3 Korea Microbiome Therapeutics Market Forecast
10.3.4 Southeast Asia Microbiome Therapeutics Market Forecast
10.3.5 India Microbiome Therapeutics Market Forecast
10.3.6 Australia Microbiome Therapeutics Market Forecast
10.4 Europe Microbiome Therapeutics Forecast by Country (2021-2026)
10.4.1 Germany Microbiome Therapeutics Market Forecast
10.4.2 France Microbiome Therapeutics Market Forecast
10.4.3 UK Microbiome Therapeutics Market Forecast
10.4.4 Italy Microbiome Therapeutics Market Forecast
10.4.5 Russia Microbiome Therapeutics Market Forecast
10.5 Middle East & Africa Microbiome Therapeutics Forecast by Region (2021-2026)
10.5.1 Egypt Microbiome Therapeutics Market Forecast
10.5.2 South Africa Microbiome Therapeutics Market Forecast
10.5.3 Israel Microbiome Therapeutics Market Forecast
10.5.4 Turkey Microbiome Therapeutics Market Forecast
10.5.5 GCC Countries Microbiome Therapeutics Market Forecast
10.6 Global Microbiome Therapeutics Forecast by Type (2021-2026)
10.7 Global Microbiome Therapeutics Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Information
11.1.2 Seres Therapeutics Microbiome Therapeutics Product Offered
11.1.3 Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Seres Therapeutics Main Business Overview
11.1.5 Seres Therapeutics Latest Developments
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Information
11.2.2 Assembly Biosciences Microbiome Therapeutics Product Offered
11.2.3 Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Assembly Biosciences Main Business Overview
11.2.5 Assembly Biosciences Latest Developments
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Information
11.3.2 Synthetic Biologics Microbiome Therapeutics Product Offered
11.3.3 Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Synthetic Biologics Main Business Overview
11.3.5 Synthetic Biologics Latest Developments
11.4 Interxon
11.4.1 Interxon Company Information
11.4.2 Interxon Microbiome Therapeutics Product Offered
11.4.3 Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Interxon Main Business Overview
11.4.5 Interxon Latest Developments
11.5 PureTech
11.5.1 PureTech Company Information
11.5.2 PureTech Microbiome Therapeutics Product Offered
11.5.3 PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 PureTech Main Business Overview
11.5.5 PureTech Latest Developments
11.6 Synlogic
11.6.1 Synlogic Company Information
11.6.2 Synlogic Microbiome Therapeutics Product Offered
11.6.3 Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Synlogic Main Business Overview
11.6.5 Synlogic Latest Developments
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Information
11.7.2 Enterome BioScience Microbiome Therapeutics Product Offered
11.7.3 Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Enterome BioScience Main Business Overview
11.7.5 Enterome BioScience Latest Developments
11.8 4D Pharma
11.8.1 4D Pharma Company Information
11.8.2 4D Pharma Microbiome Therapeutics Product Offered
11.8.3 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 4D Pharma Main Business Overview
11.8.5 4D Pharma Latest Developments
11.9 Second Genome
11.9.1 Second Genome Company Information
11.9.2 Second Genome Microbiome Therapeutics Product Offered
11.9.3 Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Second Genome Main Business Overview
11.9.5 Second Genome Latest Developments
11.10 AOBiome
11.10.1 AOBiome Company Information
11.10.2 AOBiome Microbiome Therapeutics Product Offered
11.10.3 AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 AOBiome Main Business Overview
11.10.5 AOBiome Latest Developments
11. C3 Jian
11.11.1 C3 Jian Company Information
11.11.2 C3 Jian Microbiome Therapeutics Product Offered
11.11.3 C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 C3 Jian Main Business Overview
11.11.5 C3 Jian Latest Developments
11.12 Rebiotix
11.12.1 Rebiotix Company Information
11.12.2 Rebiotix Microbiome Therapeutics Product Offered
11.12.3 Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Rebiotix Main Business Overview
11.12.5 Rebiotix Latest Developments
11.13 MicroBiome Therapeutics LLC
11.13.1 MicroBiome Therapeutics LLC Company Information
11.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Offered
11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 MicroBiome Therapeutics LLC Main Business Overview
11.13.5 MicroBiome Therapeutics LLC Latest Developments
11.14 Metabiomics
11.14.1 Metabiomics Company Information
11.14.2 Metabiomics Microbiome Therapeutics Product Offered
11.14.3 Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Metabiomics Main Business Overview
11.14.5 Metabiomics Latest Developments
11.15 Ritter Pharmaceuticals
11.15.1 Ritter Pharmaceuticals Company Information
11.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Offered
11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Ritter Pharmaceuticals Main Business Overview
11.15.5 Ritter Pharmaceuticals Latest Developments
11.16 Symberix
11.16.1 Symberix Company Information
11.16.2 Symberix Microbiome Therapeutics Product Offered
11.16.3 Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Symberix Main Business Overview
11.16.5 Symberix Latest Developments
11.17 OpenBiome
11.17.1 OpenBiome Company Information
11.17.2 OpenBiome Microbiome Therapeutics Product Offered
11.17.3 OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 OpenBiome Main Business Overview
11.17.5 OpenBiome Latest Developments
11.18 Azitra
11.18.1 Azitra Company Information
11.18.2 Azitra Microbiome Therapeutics Product Offered
11.18.3 Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Azitra Main Business Overview
11.18.5 Azitra Latest Developments
11.19 Symbiotix Biotherapies
11.19.1 Symbiotix Biotherapies Company Information
11.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Offered
11.19.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Symbiotix Biotherapies Main Business Overview
11.19.5 Symbiotix Biotherapies Latest Developments
11.20 Osel
11.20.1 Osel Company Information
11.20.2 Osel Microbiome Therapeutics Product Offered
11.20.3 Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Osel Main Business Overview
11.20.5 Osel Latest Developments
11.21 Metabogen
11.21.1 Metabogen Company Information
11.21.2 Metabogen Microbiome Therapeutics Product Offered
11.21.3 Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 Metabogen Main Business Overview
11.21.5 Metabogen Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Microbiome Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Upper GIT
Table 3. Major Players of Lower GIT
Table 4. Microbiome Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Microbiome Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Microbiome Therapeutics Market Size Market Share by Type (2016-2021)
Table 7. Microbiome Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Microbiome Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Microbiome Therapeutics Market Size Market Share by Application (2016-2021)
Table 10. Global Microbiome Therapeutics Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Microbiome Therapeutics Revenue Market Share by Players (2019-2021E)
Table 12. Microbiome Therapeutics Key Players Head office and Products Offered
Table 13. Microbiome Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Microbiome Therapeutics Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Microbiome Therapeutics Market Size Market Share by Regions 2016-2021
Table 18. Americas Microbiome Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Microbiome Therapeutics Market Size Market Share by Country (2016-2021)
Table 20. Americas Microbiome Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Microbiome Therapeutics Market Size Market Share by Type (2016-2021)
Table 22. Americas Microbiome Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Microbiome Therapeutics Market Size Market Share by Application (2016-2021)
Table 24. APAC Microbiome Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Microbiome Therapeutics Market Size Market Share by Region (2016-2021)
Table 26. APAC Microbiome Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Microbiome Therapeutics Market Size Market Share by Type (2016-2021)
Table 28. APAC Microbiome Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Microbiome Therapeutics Market Size Market Share by Application (2016-2021)
Table 30. Europe Microbiome Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Microbiome Therapeutics Market Size Market Share by Country (2016-2021)
Table 32. Europe Microbiome Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Microbiome Therapeutics Market Size Market Share by Type (2016-2021)
Table 34. Europe Microbiome Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Microbiome Therapeutics Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Microbiome Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Microbiome Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Microbiome Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Microbiome Therapeutics
Table 43. Key Application and Potential Industries of Microbiome Therapeutics
Table 44. Key Challenges of Microbiome Therapeutics
Table 45. Key Trends of Microbiome Therapeutics
Table 46. Global Microbiome Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Microbiome Therapeutics Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Microbiome Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Microbiome Therapeutics Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Microbiome Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Microbiome Therapeutics Market Size Market Share Forecast by Application (2021-2026)
Table 52. Seres Therapeutics Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 53. Seres Therapeutics Microbiome Therapeutics Product Offered
Table 54. Seres Therapeutics Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Seres Therapeutics Main Business
Table 56. Seres Therapeutics Latest Developments
Table 57. Assembly Biosciences Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 58. Assembly Biosciences Microbiome Therapeutics Product Offered
Table 59. Assembly Biosciences Main Business
Table 60. Assembly Biosciences Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Assembly Biosciences Latest Developments
Table 62. Synthetic Biologics Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 63. Synthetic Biologics Microbiome Therapeutics Product Offered
Table 64. Synthetic Biologics Main Business
Table 65. Synthetic Biologics Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Synthetic Biologics Latest Developments
Table 67. Interxon Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 68. Interxon Microbiome Therapeutics Product Offered
Table 69. Interxon Main Business
Table 70. Interxon Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Interxon Latest Developments
Table 72. PureTech Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 73. PureTech Microbiome Therapeutics Product Offered
Table 74. PureTech Main Business
Table 75. PureTech Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. PureTech Latest Developments
Table 77. Synlogic Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 78. Synlogic Microbiome Therapeutics Product Offered
Table 79. Synlogic Main Business
Table 80. Synlogic Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Synlogic Latest Developments
Table 82. Enterome BioScience Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 83. Enterome BioScience Microbiome Therapeutics Product Offered
Table 84. Enterome BioScience Main Business
Table 85. Enterome BioScience Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Enterome BioScience Latest Developments
Table 87. 4D Pharma Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 88. 4D Pharma Microbiome Therapeutics Product Offered
Table 89. 4D Pharma Main Business
Table 90. 4D Pharma Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. 4D Pharma Latest Developments
Table 92. Second Genome Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 93. Second Genome Microbiome Therapeutics Product Offered
Table 94. Second Genome Main Business
Table 95. Second Genome Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Second Genome Latest Developments
Table 97. AOBiome Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 98. AOBiome Microbiome Therapeutics Product Offered
Table 99. AOBiome Main Business
Table 100. AOBiome Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. AOBiome Latest Developments
Table 102. C3 Jian Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 103. C3 Jian Microbiome Therapeutics Product Offered
Table 104. C3 Jian Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. C3 Jian Main Business
Table 106. C3 Jian Latest Developments
Table 107. Rebiotix Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 108. Rebiotix Microbiome Therapeutics Product Offered
Table 109. Rebiotix Main Business
Table 110. Rebiotix Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 111. Rebiotix Latest Developments
Table 112. MicroBiome Therapeutics LLC Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 113. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Offered
Table 114. MicroBiome Therapeutics LLC Main Business
Table 115. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. MicroBiome Therapeutics LLC Latest Developments
Table 117. Metabiomics Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 118. Metabiomics Microbiome Therapeutics Product Offered
Table 119. Metabiomics Main Business
Table 120. Metabiomics Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Metabiomics Latest Developments
Table 122. Ritter Pharmaceuticals Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 123. Ritter Pharmaceuticals Microbiome Therapeutics Product Offered
Table 124. Ritter Pharmaceuticals Main Business
Table 125. Ritter Pharmaceuticals Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. Ritter Pharmaceuticals Latest Developments
Table 127. Symberix Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 128. Symberix Microbiome Therapeutics Product Offered
Table 129. Symberix Main Business
Table 130. Symberix Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 131. Symberix Latest Developments
Table 132. OpenBiome Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 133. OpenBiome Microbiome Therapeutics Product Offered
Table 134. OpenBiome Main Business
Table 135. OpenBiome Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 136. OpenBiome Latest Developments
Table 137. Azitra Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 138. Azitra Microbiome Therapeutics Product Offered
Table 139. Azitra Main Business
Table 140. Azitra Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 141. Azitra Latest Developments
Table 142. Symbiotix Biotherapies Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 143. Symbiotix Biotherapies Microbiome Therapeutics Product Offered
Table 144. Symbiotix Biotherapies Main Business
Table 145. Symbiotix Biotherapies Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 146. Symbiotix Biotherapies Latest Developments
Table 147. Osel Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 148. Osel Microbiome Therapeutics Product Offered
Table 149. Osel Main Business
Table 150. Osel Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 151. Osel Latest Developments
Table 152. Metabogen Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 153. Metabogen Microbiome Therapeutics Product Offered
Table 154. Metabogen Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 155. Metabogen Main Business
Table 156. Metabogen Latest Developments
List of Figures
Figure 1. Microbiome Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microbiome Therapeutics Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Microbiome Therapeutics Market Size Market Share by Type in 2020
Figure 7. Microbiome Therapeutics in C. difficile Infection (CDI)
Figure 8. Global Microbiome Therapeutics Market: C. difficile Infection (CDI) (2016-2021) & ($ Millions)
Figure 9. Microbiome Therapeutics in Inflammatory Bowel Disease (IBD)
Figure 10. Global Microbiome Therapeutics Market: Inflammatory Bowel Disease (IBD) (2016-2021) & ($ Millions)
Figure 11. Microbiome Therapeutics in Orphan Drug
Figure 12. Global Microbiome Therapeutics Market: Orphan Drug (2016-2021) & ($ Millions)
Figure 13. Microbiome Therapeutics in Immuno-oncology
Figure 14. Global Microbiome Therapeutics Market: Immuno-oncology (2016-2021) & ($ Millions)
Figure 15. Microbiome Therapeutics in Others
Figure 16. Global Microbiome Therapeutics Market: Others (2016-2021) & ($ Millions)
Figure 17. Global Microbiome Therapeutics Market Size Market Share by Application in 2020
Figure 18. Global Microbiome Therapeutics Revenue Market Share by Player in 2020
Figure 19. Global Microbiome Therapeutics Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Microbiome Therapeutics Market Size 2016-2021 ($ Millions)
Figure 21. APAC Microbiome Therapeutics Market Size 2016-2021 ($ Millions)
Figure 22. Europe Microbiome Therapeutics Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Microbiome Therapeutics Market Size 2016-2021 ($ Millions)
Figure 24. Americas Microbiome Therapeutics Market Size Market Share by Country in 2020
Figure 25. Americas Microbiome Therapeutics Market Size Market Share by Type in 2020
Figure 26. Americas Microbiome Therapeutics Market Size Market Share by Application in 2020
Figure 27. United States Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Microbiome Therapeutics Market Size Market Share by Regions in 2020
Figure 31. APAC Microbiome Therapeutics Market Size Market Share by Type in 2020
Figure 32. APAC Microbiome Therapeutics Market Size Market Share by Application in 2020
Figure 33. China Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Microbiome Therapeutics Market Size Market Share by Country in 2020
Figure 40. Europe Microbiome Therapeutics Market Size Market Share by Type in 2020
Figure 41. Europe Microbiome Therapeutics Market Size Market Share by Application in 2020
Figure 42. Germany Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Application in 2020
Figure 50. Egypt Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Country Microbiome Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 56. APAC Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 57. Europe Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 59. United States Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 60. Canada Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 63. China Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 64. Japan Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 65. Korea Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 67. India Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 68. Australia Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 69. Germany Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 70. France Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 71. UK Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 72. Italy Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 73. Russia Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 74. Spain Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 77. Israel Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Microbiome Therapeutics Market Size 2021-2026 ($ Millions)
Figure 79. GCC Country Microbiome Therapeutics Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 마이크로바이옴 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02229) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 마이크로바이옴 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 마이크로바이옴 치료 및 진단 시장예측 2021년-2026년
LPI-2201K02344 / LP Information / 2021년 12월 / 본 조사보고서는 마이크로바이옴 치료 및 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Microbiome Therapeutics and Diagnostics will have significant change from previous year. By the most conservative estimates of global Microbiome Therapeutics and Diagnostics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX...

세계의 인체 마이크로바이옴 시장예측 2021년-2026년
LPI-2201K00136 / LP Information / 2021년 12월 / 본 조사보고서는 인체 마이크로바이옴의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Human Microbiome will have significant change from previous year. By the most conservative estimates of global Human Microbiome market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 309.3 million in 2020. Over...

세계의 표적 단백질 분해 치료제 시장예측 2021년-2026년
LPI-2201K02312 / LP Information / 2021년 12월 / 본 조사보고서는 표적 단백질 분해 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Targeted-protein Degradation Therapeutics will have significant change from previous year. By the most conservative estimates of global Targeted-protein Degradation Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 혈우병 A 및 B 치료제 시장예측 2021년-2026년
LPI-2201K00221 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Hemophillia A and B Therapeutics Materials will have significant change from previous year. By the most conservative estimates of global Hemophillia A and B Therapeutics Materials market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in...

세계의 올리고뉴클레오티드 치료제 시장예측 2021년-2026년
LPI-2201K02248 / LP Information / 2021년 12월 / 본 조사보고서는 올리고뉴클레오티드 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Oligonucleotide Therapeutics will have significant change from previous year. By the most conservative estimates of global Oligonucleotide Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3083.2 million in 2020. Over...

세계의 소양증 치료제 시장예측 2021년-2026년
LPI-2201K02285 / LP Information / 2021년 12월 / 본 조사보고서는 소양증 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pruritus Therapeutics will have significant change from previous year. By the most conservative estimates of global Pruritus Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 12760 million in 2020. Over...

세계의 혈우병 치료제 시장예측 2021년-2026년
LPI-2201K00121 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Hemophilia Therapeutics will have significant change from previous year. By the most conservative estimates of global Hemophilia Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 9275.3 million in 2020. Over...

세계의 mRNA 암 백신 및 치료제 시장예측 2021년-2026년
LPI-2201K02233 / LP Information / 2021년 12월 / 본 조사보고서는 mRNA 암 백신 및 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of mRNA Cancer Vaccines and Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Cancer Vaccines and Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...